News

Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...
How did we get here? Until now, vaccines for all children under age 12 had been available under emergency use authorization ...
According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, ...
Pfizer (PFE) and BioNTech (BNTX) challenge Moderna's patent win in London court over mRNA COVID-19 vaccine technology. Read ...
US regulators have fully approved Moderna's Spikevax COVID-19 vaccine for children aged 6 months to 11 years, but only for ...
A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...
Explore more
Pfizer and Moderna will now include more information on the risk of myocarditis on their COVID-19 vaccine labels.
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
The new memos from the Food and Drug Administration show how the agency’s vaccine chief, Dr. Vinay Prasad, personally ...
If RFK has his way, even if you still have coverage, you may not be able to afford the shots that your doctor wants to give.